Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptor-α

Oncogene

Volumn 30, Issue 13, 2011, Pages 1608-1614

  Merrell, K W ^a   Crofts, J D ^a   Smith, R L ^a   Sin, J H ^a   Kmetzsch, K E ^a   Merrell, A ^a   Miguel, R O ^a   Candelaria, N R ^a   Lin, C Y ^a,b  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b University of Houston   (United States)

Author keywords

coregulators; estrogen receptor; hormonal carcinogenesis; transcriptional regulation

Indexed keywords

ANTIESTROGEN; CYCLIN G2; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HISTONE; LCOR PROTEIN; NUCLEAR PROTEIN; NUCLEAR RECEPTOR COREPRESSOR; PROTEIN P300; RALOXIFENE; REA PROTEIN; RECEPTOR INTERACTING PROTEIN 140; RNA POLYMERASE II; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; TAMOXIFEN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER HORMONE THERAPY; CANCER PATIENT; DISEASE COURSE; GENE EXPRESSION; GENE TARGETING; HISTONE MODIFICATION; HUMAN; MOLECULAR DOCKING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN RNA BINDING; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CO-REPRESSOR PROTEINS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; LIGANDS; NUCLEAR PROTEINS; NUCLEAR RECEPTOR CO-REPRESSOR 1; NUCLEAR RECEPTOR CO-REPRESSOR 2; REPRESSOR PROTEINS; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

EID: 79953171856     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.528     Document Type: Article

References (44)

1. Ali S, Coombes RC. (2000). Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia 5: 271-281. (Pubitemid 32156528)
2. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY et al. (1997). AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968. (Pubitemid 27366683)
3. Bookman MA. (2005). Is there still a role for hormonal therapy? Int J Gynecol Cancer 15(Suppl 3): 291-297. (Pubitemid 43096596)
4. Cappelletti V, Celio L, Bajetta E, Allevi A, Longarini R, Miodini P et al. (2004). Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients. Endocr Relat Cancer 11: 761-770. (Pubitemid 40065549)
5. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ et al. (2005). Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43. (Pubitemid 40977938)
6. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J et al. (2006). Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297. (Pubitemid 44646291)
7. Cavailles V, Dauvois S, Lhorset F, Lopez G, Hoare S, Kushner PJ et al. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. Embo J 14: 3741-3751.
8. Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT et al. (1999). Regulation of transcription by a protein methyltransferase. Science 284: 2174-2177. (Pubitemid 29297477)
9. Chen JD, Evans RM. (1995). A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457.
10. Fernandes I, Bastien Y, Wai T, Nygard K, Lin R, Cormier O et al. (2003). Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell 11: 139-150. (Pubitemid 36126597)
11. Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS et al. (2001). RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem 276: 42259-42267.
12. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A et al. (2005). Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97: 1652-1662. (Pubitemid 41672231)
13. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM et al. (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388. (Pubitemid 28439961)
14. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbo-gen BS. (2003). Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574. (Pubitemid 37204856)
15. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. (2002). Production and actions of estrogens. N Engl J Med 346: 340-352.
16. Guenther MG, Barak O, Lazar MA. (2001). The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21: 6091-6101. (Pubitemid 34263509)
17. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M. (1994). Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264: 1455-1458.
18. Hebbes TR, Thorne AW, Crane-Robinson C. (1988). A direct link between core histone acetylation and transcriptionally active chromatin. Embo J 7: 1395-1402.
19. Hu X, Lazar MA. (1999). The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402: 93-96.
20. Lin CY, Strom A, Li Kong S, Kietz S, Thomsen JS, Tee JB et al (2007a). Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res 9: R25.
21. Lin CY, Strom A, Vega VB, Kong SL, Yeo AL, Thomsen JS et al (2004). Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol 5: R66.
22. Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M et al (2007b). Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 3: e87.
23. Lin WJ, Gary JD, Yang MC, Clarke S, Herschman HR. (1996). The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271: 15034-15044. (Pubitemid 26197578)
24. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA et al (2003). Estrogen Receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a 'Ying Yang' relationship between ERalpha and ERbeta in Mice. Mol Endocrinol 17: 203-208. (Pubitemid 36187395)
25. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M et al. (2003). Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763. (Pubitemid 38030303)
26. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A et al. (2005). An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102: 13550-13555. (Pubitemid 41420886)
27. Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen BS. (1999). An estrogen receptor-selective cor-egulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci USA 96: 6947-6952. (Pubitemid 29274990)
28. Nilsson S, Gustafsson JA. (2002). Estrogen receptor action. Crit Rev Eukaryot Gene Expr 12: 237-257. (Pubitemid 37051498)
29. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959. (Pubitemid 26404293)
30. Onate SA, Tsai SY, Tsai MJ, O'Malley BW. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
31. Phelan ML, Sif S, Narlikar GJ, Kingston RE. (1999). Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3: 247-253. (Pubitemid 29292625)
32. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. (2000). Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
33. Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L et al. (1996). The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohisto-chemistry. J Natl Cancer Inst 88: 173-182. (Pubitemid 26065829)
34. Soulez M, Parker MG. (2001). Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 27: 259-274. (Pubitemid 33130125)
35. Sterner DE, Berger SL. (2000). Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64: 435-459. (Pubitemid 30412680)
36. Stossi F, Likhite VS, Katzenellenbogen JA, Katzenellenbogen BS. (2006). Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J Biol Chem 281: 16272-16278.
37. Stossi F, Madak-Erdogan Z, Katzenellenbogen BS. (2009). Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.Mol Cell Biol 29: 1749-1759.
38. Treuter E, Albrektsen T, Johansson L, Leers J, Gustafsson JA. (1998). A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol 12: 864-881. (Pubitemid 30659060)
39. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN et al. (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. Jama 295: 2727-2741.
40. Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, Strahl BD et al. (2001). Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293: 853-857. (Pubitemid 32743973)
41. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR et al. (1996). Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. Embo J 15: 5370-5382. (Pubitemid 26336219)
42. Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL et al. (2000). The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 14: 1976-1985. (Pubitemid 32055531)
43. Wei LN, Hu X, Chandra D, Seto E, Farooqui M. (2000). Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J Biol Chem 275: 40782-40787. (Pubitemid 32054897)
44. Yager JD, Davidson NE. (2006). Estrogen carcinogenesis in breast cancer. N Engl J Med 354: 270-282.